The American Academy of Actuaries has developed a report discussing the risk factors that regulators might consider when evaluating risk-based capital levels for Medicare Part D prescription drug plans.[@@]
The new report, based on recommendations published in September, includes actual numerical values for the proposed risk factors, according to the AAA, Washington.